Tandem Therapeutics AG
About
TANDEM Therapeutics is a discovery stage Swiss biopharmaceutical company bringing a novel precision targeting approach to fibrosis and fibrotic cancers. As a ETH Zürich and Paul Scherrer Institute Spin-off, we advance transformative research and development in the field of extracellular matrix biology and the critical role it plays in the pathology of fibrotic diseases.
Target Markets of your organization / Expansion or target markets of your spin-off
SwitzerlandUSEMEAAPACGlobal
Industry Sector your organization invests in / Industry Sector of your Spin-off
Bio Tech
Representatives
Co-founder & CEO
Tandem Therapeutics AG